Alpha Cognition Inc., a clinical stage biopharmaceutical company, engages in the development of treatments for Alzheimer's disease and amyotrophic lateral scler…
$8.29+1.72%
报价 2026-11-06
市值
$128.8M
EV
$50.8M
PE (TTM)
–
预期 PE
–
52 周区间距高点 -15.0%
$4.50$9.75
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Financial - Conglomerates| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| ACOGAlpha Cognition Inc. Common Stock | $128.8M | +1.7% | – | 73.1% | – | – | – | |
| NCOSouthern Cross Acquisition I Corp. | $146.7M | +0.2% | – | – | – | – | – | |
| FWACFuturewave Acquisition Corp. | $128.1M | +0.1% | – | – | – | – | – | |
| EWAVEast West Ave Acquisition Corp. Common Stock | $127.2M | -0.4% | – | – | – | – | – | |
| NCOOUSouthern Cross Acquisition I Corp. | $118.2M | -0.3% | – | – | – | – | – | |
| FACCartesian Growth Corporation III Class A Ordinary Shares | $117.3M | +7.6% | – | 0% | – | – | – | |
| PLUNPlutonian Acquisition Corp II | $115.7M | +0.4% | – | – | – | – | – | |
| FXACFortuneX Acquisition Corp | $114.3M | +0.1% | – | – | – | – | – | |
| SAGUShreya Acquisition Group | $113.3M | +0.4% | – | – | – | – | – | |
| 同行中位数 | – | – | – | 0% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。